Business
Microbot Medical Secures Patent for LIBERTY® Robotic System in the United States
HINGHAM, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has
About this update from Microbot Medical Inc.
[{"type":"text","content":"HINGHAM, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance covering the Company’s LIBERTY® Robotic System. Globally, the Company now has 45 patents issued/allowed and 24 pending patent applications. “This achievement is yet another meaningful milestone that adds a secure foundation to build our sustainable competitive advantage. This IP allows us to protect our assets globally and advance towards commercialization,” commented Harel Gadot, CEO, President and Chairman. “We believe our novel technology is uniquely positioned to transform catheter-based procedures and benefit more patients globally while keeping physicians safe from radiation and reducing their physical strain.” The allowed patent pertains to a device for automatically inserting and manipulating a medical tool into and within a bodily lumen. The allowed claims cover a compact robotic drive for driving and manipulating movement of at least one elongate surgical tool, the robotic drive includes a housing comprising motors and a first tool-moving element driven by the motors, positioned and configured to advance or retract the elongate surgical tool, and a second tool-moving element driven by the motors, configured to roll the elongate surgical tool about the long axis. About Microbot Medical Microbot Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot’s current proprietary technological platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP). Microbot Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical is available at http://www.microbotmedical.com. Safe Harbor Statements pertaining to the registered direct offering, timing, the amount and anticipated use of proceeds and statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities f...